Clinical Trial 50927

Berlin, NJ 08009


A double-blind, placebo-controlled, Phase IIb, multi-center, 10-week prospective study to evaluate the efficacy and safety of NOE-105 in adult male patients with childhood onset fluency disorder.

  • Be 18-50 years old
  • Be male
  • Have childhood onset fluency disorder (stuttering)
  • Discontinue all medications used to treat stuttering for at least 14 dyas prior to screening
  • Have a history of stuttering for 2 years with onset conistent to developmental in nature before age 8 years

Qualified Participants May Receive:

  • Up to $2,810 for time and travel
  • No insurance needed and transportation available

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.